Review

Blood Transfusion - 4 2022 (July-August)

Prevalence of Chikungunya, Dengue and Zika viruses in blood donors: a systematic literature review and meta-analysis

Authors

Key words: Chikungunya virus, Dengue virus, Zika virus, blood transfusion, blood safety
Publication Date: 2021-09-22

Abstract

 Background - Blood transfusion centres should understand the epidemiology of emerging diseases that are transmissible through the transfusion of blood components. The risk of transmission of arboviruses through this route has become apparent in recent years. The aim of our study is to summarise the reported prevalence (viraemic rate, seroprevalence and/or antigen detection) of Chikungunya (CHIKV), Dengue (DENV) and Zika (ZIKV) viruses in blood donors according to screening test used and world region.
Materials and methods - We conducted a systematic literature review and meta-analysis having searched for information in the main bibliographic databases (MEDLINE, Embase, and Scopus). The prevalence for each of the viruses was calculated according to the screening test used and geographic location.
Results - We included 18 records on CHIKV, 71 on DENV, and 27 on ZIKV. The highest prevalences of RNA for CHIKV were 1.9% in Puerto Rico (2014), 1.0% in Thailand (2009), and 1.0% in French Polynesia (2014-15). The highest prevalences of RNA for DENV were 5.5% in Saudi Arabia (2015-16), 2.3% in Madeira, Portugal (2012-13), and 0.6% in Brazil (2012). The highest prevalences of RNA for ZIKV were 2.8% in French Polynesia (2013-14), 2.7% in Brazil (2015-16), and 1.8% in Martinique (2016). Overall seroprevalence, as assessed by IgG antibodies, was 21.6% for CHIKV, 24.0% for DENV, and 5.1% for ZIKV.
Discussion - Our study shows a high proportion of donors who are viraemic and asymptomatic, especially during outbreaks, with prevalences surpassing 5% for DENV, 1% for CHIKV, and 2% for ZIKV. These data confirm a clear threat to blood transfusion safety. The elevated seroprevalence for these three arboviruses is also indicative of their wide circulation in populations, correlating with an increased risk of infected but asymptomatic donors. Health centres and institutions must address this threat, especially in tropical regions where the biggest outbreaks occur.

Downloads

Authors

Ángel Giménez-Richarte - Valencian Community Blood Transfusion Centre, Valencian Community, Spain

Mabel Ortiz de Salazar - Valencian Community Blood Transfusion Centre, Valencian Community, Spain

Cristina Arbona - Valencian Community Blood Transfusion Centre, Valencian Community, Spain

María P. Giménez-Richarte - Medical student, Miguel Hernandez University of Elche, Alicante, Spain

Miriam Collado - Valencian Community Blood Transfusion Centre, Valencian Community, Spain

Pedro L. Fernández - Valencian Community Blood Transfusion Centre, Valencian Community, Spain

Francisco Quiles - Valencian Community Blood Transfusion Centre, Valencian Community, Spain

Carlos Clavijo - Valencian Community Blood Transfusion Centre, Valencian Community, Spain

Pascual Marco - Service of Haematology, General University Hospital of Alicante-ISABIAL, Alicante, Spain; Clinical Medicine Department, Miguel Hernandez University of Elche, Alicante, Spain

Jose-Manuel Ramos-Rincon - Clinical Medicine Department, Miguel Hernandez University of Elche, Alicante, Spain

  • Abstract viewed - 1019 times
  • PDF downloaded - 667 times